Diagnosis → Ophthalmology
Conjunctivitis
Inflammation of the conjunctival tissue, engorgement of the blood vessels, pain, and ocular discharge.
Acute: symptom duration <4 weeks
Chronic: symptom duration >4 weeks
Also known as: Pink eye
Etiology
Cause [s4r]
Viral: Adenovirus (most common), HSV, VZV, Molluscum contagiosum, enterovirus
Bacterial: S. aureus, S. pneumoniae, H. influenzae, S. pneumoniae, Moraxella spp
Sexually transmitted or neonates: Chlamydia trachomatis, Neisseria gonorrhoeae
Allergic: Seasonal/perennial allergic conjunctivitis; atopic keratoconjunctivitis
Toxic/chemical/medicamentosa: Irritants; topical medication/preservative toxicity
Mechanical/ocular surface disease: Contact lens, giant papillary conjunctivitis, blepharoconjunctivitis, keratoconjunctivitis sicca, foreign body, mucus fishing
Immunological: Pemphigoid, SJS/TEN, GVHD, vasculitis, Reiter syndrome
Metabolic disease: Vitamin A deficiency, porphyria and Richner-Hanhart syndrome
Masquerades (neoplastic): Sebaceous carcinoma, ocular surface squamous neoplasia, melanoma; ligneous conjunctivitis
Pathophysiology
Trigger at conjunctival surface
Infection
Allergen
Irritant/medicament
Mechanical friction
Autoimmune basement-membrane targeting
Inflammatory response
Conjunctival vasodilation → conjunctival injection/red eye
Exudation/mucus production → watery vs mucopurulent discharge
Viral: Bilateral affection and enlarged preauricular lymph node
Allergic: Bilateral, watery/stringy mucus with pruritus
Toxic: Exposure history
Mechanical: Contact lens, foreign body
Masquerade: Unilateral chronic/nonresponsive, tumor, lash loss, recurrent “blepharitis” → consider neoplasia (sebaceous carcinoma)
Risk factors
Contact lens wear
Close-contact exposure/daycare/school outbreaks (adenovirus)
Atopy/asthma/eczema (allergic, atopic keratoconjunctivitis)
Sexual activity/new partner (chlamydial/gonococcal)
Immunocompromise
Chronic topical medicaments
Systemic immune disease (OMMP, SJS/TEN, GVHD, vasculitis)
Complications
Corneal involvement: Keratitis, corneal ulceration, scarring, vision loss
Membranous conjunctivitis
Progressive conjunctival scarring/symblepharon/fornix foreshortening
Neonatal systemic disease association
Epidemiology
Incidence per 100.000 [s4r][igv][f68]
Default
Symptoms & findings
Symptoms
Blurred vision, Coryza, Fever, Headache, Lacrimation, Lymphadenopathy, Mucopus, Photophobia, Pruritus, Red eye, Sore throat
Clinical findings
Anamneses
None listed.
Localized findings
Approach
Clinical approach [s4r]
Visual acuity
Corneal staining/defect
Anterior chamber reaction
Severe purulent discharge
Culture/Gram stain from eyelid
Chlamydia PCR
Adenovirus rapid antigen test
Biopsy: Suspected OMMP or neoplasia
Diagnostic criteria
Red eye + conjunctival injection
Preserved vision
No evidence of keratitis/uveitis/acute angle closure/orbital cellulitis
Treatment
Usually self-limiting [s4r]
Supportive care: Lubricants/artificial tears, cold compresses
Remove contact lenses
Avoid routine topical antibiotics and topical corticosteroids
Exclude red-eye emergencies
Allergic: Allergen avoidance and topical antihistamine
Viral: Consider antiviral therapy with topical ganciclovir 0.15% gel 1 drop 5 times/day
Bacterial: Symptomatic treatment, short course of broad-spectrum topical antibiotic
Gonococcal conjunctivitis: Ceftriaxone 1 g IM
Differential diagnoses
Blepharitis, Cancer, Chalazion, Corneal abrasion, Corneal ulcer, Episcleritis, Foreign body, Glaucoma, Hordeolum, Iridocyclitis, Keratitis, Keratoconjunctivitis sicca, Periorbital cellulitis, Pterygium, Scleritis, Sjogren syndrome, Stevens-Johnson syndrome, Subconjunctival hemorrhage, Toxic epidermal necrolysis
References
[1] Hashmi MF, Gurnani B, Benson S. Conjunctivitis. [Updated 2024 Jan 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK541034/
[2] Rietveld, R.P., ter Riet, G., Bindels, P.J. et al. Do general practitioners adhere to the guideline on infectious conjunctivitis? Results of the Second Dutch National Survey of General Practice. BMC Fam Pract 8, 54 (2007).
[3] Gertrude Abbo et al. Spatial and temporal trends of conjunctivitis in Uganda, 2020–2023: A nationwide surveillance analysis. Journal of Interventional Epidemiology and Public Health. 2026; 9(1):37
[4] Rose, P. (2007). Management strategies for acute infective conjunctivitis in primary care: a systematic review. Expert Opinion on Pharmacotherapy, 8(12), 1903–1921.